About
GlycosBio develops engineered lipid-based technologies that improve the therapeutic performance and bioavailability of natural bioactive molecules, focusing on microbiota modulation and lipid engineering for medical and nutritional applications.
Explore GlycosBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.